Lexaria Bioscience Corp Ordinary Shares LEXX 深 沪
等待开盘 12-19 09:30:00 美东时间
0.6851
+0.004
+0.51%
华盛通- 最 高0.715
- 今 开0.699
- 成交量 47.23万股
- 最 低 0.66
- 昨 收 0.6816
- 总市值 1340.00万
- 52周最高 2.43
- 市盈率 静 --
- 换手率 2.41%
- 52周最低 0.66
- 委 比 -14.78%
- 总股本 1955.92万
- 历史最高 12.50
- 量 比 0.59
- 振 幅 8.07%
- 历史最低 0.6488
- 每 手 1
- 风险率 0.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Lexaria Bioscience (NASDAQ:LEXX) stock increased by 6.5% to $0.89 durin...
12-17 05:05
UPDATE: Lexaria Bioscience Announces $3.5M Registered Direct Offering Of 2,661,600 Shares At A Price Of $1.315/Share
Lexaria Bioscience Corp. (NASDAQ:LEXX)(LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, today announced that it has entered into a definitive agreement for the purchase and sale of an
12-15 21:51
Lexaria Extends Partnership With PharmaCO To April 2026 For Ongoing Evaluation Of DehydraTECH, Following Australian Study Data Review
Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, provides this update on the Material Transfer Agreement ("MTA") originally entered into on
11-12 22:12
Lexaria Bioscience Expands Strategic Outreach and Secures New Patents
Lexaria Bioscience ( ($LEXX) ) has shared an update. Lexaria Bioscience Corp. h...
10-09 23:08
Lexaria Awarded 4 New Patents Covering Therapeutics For Diabetes, Hypertension, Seizure Disorders, And Antiviral Treatments
Lexaria is pleased to announce that it has been awarded 4 new patents, continuing to build upon our already significant intellectual property portfolio. These patents support the immense value of our strategic R&D
10-09 21:23
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.
09-27 01:05
加拿大药企Lexaria Bioscience早盘重挫27.4%
加拿大药企Lexaria Bioscience(LEXX)早盘下跌27.4%，此前该公司宣布终止与JonesTrading的500万美元股票销售协议。这一决定反...
09-26 23:03
Lexaria Bioscience announces ~$4M registered direct offering of shares
Lexaria Bioscience (NASDAQ:LEXX) was trading lower after the drug delivery platform announced a sale of 2,666,667 shares, par value $0.001 per share, at $1.50 per share in a registered direct offering...
09-26 20:18
Lexaria Bioscience stock soars after ending $5M stock sale agreement with JonesTrading
Lexaria Bioscience (NASDAQ:LEXX) rose 32% in premarket trading on Friday after the company announced the termination of its Capital on-Demand Sales Agreement with JonesTrading Institutional Services L...
09-26 17:30
Why Are Lexaria Bioscience Shares Soaring 45% After Hours?
Lexaria Bioscience Corp. (NASDAQ: LEXX) experienced a dramatic 45.10% surge in after-hours trading on Thursday, climbing to $2.22 from its closing price of $1.53.
09-26 12:00
